[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Immunology](https://durgical.com/en/immunology/) › [Adaptive immunity](https://durgical.com/en/immunology/areas/adaptive/) › B-cell development: pro-B, pre-B and the pre-BCR checkpoint

# B-cell development: pro-B, pre-B and the pre-BCR checkpoint

- Process

B cells are built in the bone marrow step by step: first the heavy chain, then a test, then the light chain; a broken step leaves the body without [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/).

Updated Nov 15, 2026

## Key points

- Heavy chain first, then light chain (κ before λ).
- Pre-BCR = μ + surrogate light chain; signals through BTK.
- BTK defect → block at pre-B → XLA: no B cells, no antibodies.
- CD20 is absent on stem cells and plasma cells: [rituximab](https://durgical.com/en/pharmacology/rituximab/) spares both.
- Naive B cells co-express IgM and IgD by [alternative splicing](https://durgical.com/en/biochemistry/topics/rna-processing/).

On this page

- The basics Key points
- What it is
- How to think about it
- Step by step
- Markers
- Common traps
- Elsewhere in DurgiPedia

- Clinical Clinical notes

- Study Test yourself

- Connections Stages, markers and related diseases
- Connections

## What it is

B lymphocytes develop in the bone marrow from haematopoietic stem cells through ordered stages defined by which antibody gene is being rearranged. The pre-B-cell receptor, made of a new heavy chain with a temporary surrogate light chain, is the key checkpoint: its signal through BTK tells the cell to multiply and move on to the light chain. Blocks at this checkpoint cause agammaglobulinaemia, and each stage has a malignant counterpart.

## How to think about it

B-cell development is a build-and-test line: each stage builds one part of the antibody and must pass a quality check before the next begins (heavy chain → pre-BCR test → light chain → self-reactivity test). So each defect blocks at a predictable point: if the heavy-chain test cannot signal (BTK, μ chain, λ5), the line stops at pre-B and the blood has almost no B cells.

## Step by step

- Haematopoietic stem cell → common lymphoid progenitor; the bone-marrow stroma supplies signals that commit it to the B lineage.
- Pro-B cell: RAG1/RAG2 and TdT rearrange the heavy-chain genes (D to J, then V to DJ).
- Pre-B cell: the new μ heavy chain pairs with the surrogate light chain (VpreB and λ5) and Igα/Igβ to form the pre-BCR.
- Pre-BCR signalling through BTK drives proliferation and stops rearrangement of the other heavy-chain allele (allelic exclusion).
- Light-chain genes rearrange, κ first and λ if κ fails, giving a complete IgM receptor: immature B cell.
- Self-reactive immature B cells edit their light chain, die or become anergic (central tolerance).
- Transitional B cells leave for the [spleen](https://durgical.com/en/anatomy/spleen/) and mature into naive B cells with IgM and IgD (alternative RNA splicing).

## Stages, markers and related diseases

| Stage | What happens | Typical markers | Disease link |
| --- | --- | --- | --- |
| [Pro-B](https://durgical.com/en/conditions/acute-leukaemia/) | Heavy-chain rearrangement | CD34, CD19, CD10, TdT | B-lymphoblastic leukaemia arises from these precursors |
| Pre-B | Pre-BCR checkpoint, proliferation | CD19, CD10, cytoplasmic μ, CD20 begins | X-linked agammaglobulinaemia (BTK), μ-chain and λ5 defects |
| Immature B | Surface IgM, tolerance tests | CD19, CD20, surface IgM | Receptor editing failure contributes to autoimmunity |
| [Mature naive B](https://durgical.com/en/conditions/chronic-lymphocytic-leukaemia/) | IgM and IgD, leaves marrow | CD19, CD20, CD21, IgM⁺ IgD⁺ | [Chronic lymphocytic leukaemia](https://durgical.com/en/conditions/chronic-lymphocytic-leukaemia/) and mantle cell lymphoma are mature B-cell neoplasms |
| Plasma cell (after activation) | Secretes antibody | CD38, CD138; CD20 lost | [Multiple myeloma](https://durgical.com/en/conditions/multiple-myeloma/) |

## Markers

- CD19 (pan-B)
- CD20 (pre-B to mature)
- CD10 (precursors, germinal centre)
- TdT (precursors)
- CD34 (stem/progenitor)
- CD138 (plasma cell)

## Clinical notes

- X-linked agammaglobulinaemia: boys with almost no circulating B cells, very low immunoglobulins and bacterial infections after maternal IgG wanes (around 6 months).
- Rituximab (anti-CD20) removes most B cells but spares stem cells and plasma cells, so antibody levels fall only slowly.
- TdT and CD10 in a marrow blast population point to precursor (lymphoblastic) leukaemia.

## Common traps

- **XLA patients have B cells that simply fail to make antibody**: they have almost no circulating B cells, because the block is at pre-B in the marrow.
- **Babies with XLA are sick from birth**: maternal IgG protects them for the first months, and infections start as it wanes (around 6 months).
- **The light chain rearranges before the heavy chain**: heavy chain comes first, then the pre-BCR checkpoint, then κ (λ only if κ fails).
- **Rituximab stops antibody production quickly**: plasma cells lack CD20, so existing antibody levels fall only slowly.
- **Plasma cells carry CD20 like other B cells**: they lose CD20 (and often CD19) and express CD38 and CD138.

## Test yourself

Think of the answer, then tap the question to see it.

## Why does a boy with XLA have normal T cells but almost no B cells in blood?

BTK is needed for pre-BCR signalling in B-cell precursors; without it they stop at the pre-B stage, while T-cell development uses other kinases.

## Why does a functional heavy chain stop the other heavy-chain allele from rearranging?

Pre-BCR signalling switches off further heavy-chain rearrangement (allelic exclusion), so each B cell makes one heavy chain and has one [specificity](https://durgical.com/en/epidemiology/specificity/).

## Why do antibody levels fall only slowly after rituximab?

Plasma cells do not express CD20, so existing plasma cells keep secreting antibody.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/immunology/b-cell-development-pro-b-pre-b-and-the-pre-bcr-checkpoint/)

## Elsewhere in DurgiPedia

- [Acute lymphoblastic leukaemia/lymphoma](https://durgical.com/en/general-pathology/acute-lymphoblastic-leukaemia-lymphoma/)
- [Hematopoiesis and bone marrow](https://durgical.com/en/histology/hematopoiesis-and-bone-marrow/)

## Connections

## Related 8

- [B cell and plasma cell](https://durgical.com/en/immunology/b-cell-and-plasma-cell/)
- [V(D)J recombination: how a few genes make billions of receptors](https://durgical.com/en/immunology/v-j-recombination-how-a-few-genes-make-billions-of-receptors/)
- [Bone marrow and hematopoiesis of immune cells](https://durgical.com/en/immunology/bone-marrow-and-hematopoiesis-of-immune-cells/)
- [B-cell (antibody) deficiencies: XLA, CVID, IgA deficiency, hyper-IgM](https://durgical.com/en/immunology/b-cell-deficiencies-xla-cvid-iga-deficiency-hyper-igm/)
- [Immune tolerance and how autoimmunity begins](https://durgical.com/en/immunology/immune-tolerance-and-how-autoimmunity-begins/)
- [BCR signalling and the CD19–CD21 coreceptor](https://durgical.com/en/immunology/bcr-signalling-and-the-cd19-cd21-coreceptor/)
- [Extrafollicular and germinal-centre B-cell responses](https://durgical.com/en/immunology/extrafollicular-and-germinal-centre-b-cell-responses/)
- [CD markers: the table to know](https://durgical.com/en/immunology/cd-markers-the-table-to-know/)

## Related conditions 2

- [Acute leukaemia (AML and ALL)](https://durgical.com/en/conditions/acute-leukaemia/)
- [Chronic lymphocytic leukaemia](https://durgical.com/en/conditions/chronic-lymphocytic-leukaemia/)

## In Pharmacology 1

- [Rituximab](https://durgical.com/en/pharmacology/rituximab/)

[← All of immunology](https://durgical.com/en/immunology/)

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: [BTK gene](https://medlineplus.gov/genetics/gene/btk/) (MedlinePlus Genetics, US National Library of Medicine, 2024); [X-linked agammaglobulinemia](https://medlineplus.gov/genetics/condition/x-linked-agammaglobulinemia/) (MedlinePlus Genetics, US National Library of Medicine, 2024); [RAG1 gene](https://medlineplus.gov/genetics/gene/rag1/) (MedlinePlus Genetics, US National Library of Medicine, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/immunology/b-cell-development-pro-b-pre-b-and-the-pre-bcr-checkpoint/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/immunology/b-cell-development-pro-b-pre-b-and-the-pre-bcr-checkpoint/
